StockData
PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc. (PTCT) income statement

PTCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/3028% above fair value
$60.23−0.13 (-0.22%)

Close on Nov 18, 2026Market cap $5.03BP/E –Yield –

PTC Therapeutics, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
12.8%
Net margin
-9.2%
Return on equity, FY2025
-104.7%

Financial strength

Current ratio
3.27
Debt to equity
-2.80
Debt to assets
16.7%
Cash to current liabilities
65.6%

Valuation

P/E ratio
–
Price to sales
4.35
Price to book
–
Dividend yield
–

See a number that looks wrong?